InhibiTic vs Risperidone
Risperidone: The Standard Treatment for Tourette Syndrome
The problem with Risperidone for Tourette
Risperidone is commonly prescribed to suppress the motor and vocal tics associated with Tourette syndrome. Like other treatments that affect dopamine levels in the brain, Risperidone works by broadly blocking or modulating dopamine receptors across the entire central nervous system.
While tic reduction can occur, patients consistently report significant cognitive side effects: working memory impairment, slowed processing speed, difficulty concentrating, emotional flattening, and a persistent mental fog that many describe as feeling "dumb" or "not like myself."
Studies show that approximately 70% of Tourette patients on dopamine-blocking medications experience cognitive side effects. Over 50% discontinue treatment within the first year — not because the medication fails to reduce tics, but because the cognitive cost is too high.
Why InhibiTic is a better alternative
InhibiTic takes a fundamentally different approach. Instead of flooding the entire brain with medication that alters dopamine signaling everywhere, InhibiTic is a non-invasive wearable headband that targets only the prefrontal cortex — and only at the exact moment a tic is about to happen.
The device uses 8-channel dry EEG to detect your unique premonitory urge signature in real time. When it identifies the brainwave pattern that precedes a tic, it delivers a brief, painless electrical pulse (tACS at 20 Hz, 1.5 mA) to the dorsolateral prefrontal cortex — the brain's own inhibitory control center. Within 50 milliseconds, your brain receives the boost it needs to suppress the tic. The rest of the time, the headband does nothing.
Key advantages over Risperidone
- No cognitive side effects: Unlike Risperidone, which affects dopamine throughout the brain, InhibiTic stimulates one small region for seconds at a time. Working memory, creativity, and emotional range remain intact.
- No systemic medication: No pills to take. No blood tests. No liver monitoring. No drug interactions. No withdrawal symptoms if you stop using it.
- You stay in control: Risperidone is passive — the drug determines your dopamine levels 24 hours a day. InhibiTic assists only when you need it. You choose when to wear it and which mode to use.
- Objective data: The companion app tracks tic frequency, stimulation events, and daily cognitive performance, giving you and your doctor hard data — unlike the subjective "how do you feel?" that guides medication dosing.
Can InhibiTic be used alongside Risperidone?
Yes. InhibiTic is designed to work independently, and there is no known interaction between low-intensity transcranial electrical stimulation and any Tourette medication. Some patients may work with their doctor to reduce their Risperidone dosage while using InhibiTic. The planned clinical trial will explicitly study combined-use outcomes. Never change your medication regimen without consulting your physician.
Ready to try a non-medication approach?
Join the waitlist for early access to InhibiTic — the first closed-loop neuroheadband for Tourette syndrome.
Join the WaitlistScientific evidence behind InhibiTic
InhibiTic is grounded in peer-reviewed neuroscience, not speculation. Transcranial alternating current stimulation (tACS) at beta frequencies has been shown to enhance prefrontal inhibitory control in multiple controlled studies (Helfrich et al., Current Biology, 2014; Feurra et al., Journal of Neuroscience, 2011). The premonitory urge — the feeling that precedes a tic — has measurable EEG signatures detectable 500–1000 ms before tic onset (Morand-Beaulieu et al., Neuroscience & Biobehavioral Reviews, 2017). Safety studies confirm tACS at currents below 2 mA produces no serious adverse effects (Antal et al., Clinical Neurophysiology, 2017).